Fetal Medicine and Gynecology Department, Medical University of Lodz, Poland.
Ginekol Pol. 2020;91(5):294. doi: 10.5603/GP.2020.0059.
The estimated prevalence of the ectopic pregnancy (EP) is 1-2% of all pregnancies. Ovarian pregnancy is a rare finding with an incidence rate of 0.15% of all pregnancies and 1-3% of ectopic gestations. The use of intrauterine device (IUD) is a significant risk factor of ectopic pregnancy. Jaydess levonorgestrel intrauterine system (LNG-IUS) is considered as an extremely reliable method of contraception with the cumulative Pearl index of approx. 0.9% after a three-year period of use. This study presents a case of failure of the Jaydess intrauterine device in situ in a female patient with positive Beta Human Chorionic Gonadotropin (serum b-HCG) who was diagnosed with right-sided ovarian ectopic pregnancy. Although LNG-IUS represents the group of the most efficient contraception methods, the risks of failure still exist and should be taken into consideration. Before the insertion, every female patient should be fully informed on the potential adverse effects by a health practitioner.
宫外孕(EP)的估计患病率为所有妊娠的 1-2%。卵巢妊娠是一种罕见的发现,其发病率为所有妊娠的 0.15%,异位妊娠的 1-3%。宫内节育器(IUD)的使用是宫外孕的一个重要危险因素。杰迪思左炔诺孕酮宫内节育系统(LNG-IUS)被认为是一种极其可靠的避孕方法,在使用三年后累积 Pearl 指数约为 0.9%。本研究报告了一例杰迪思宫内节育器在原位失败的病例,患者为血清β人绒毛膜促性腺激素(β-HCG)阳性的女性,诊断为右侧卵巢宫外孕。尽管 LNG-IUS 代表了最有效的避孕方法之一,但仍存在失败的风险,应予以考虑。在插入之前,每位女性患者都应由医疗保健从业者充分告知潜在的不良反应。